Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03243084 · ClinicalTrials.gov registry record · NA
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03243084 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 21 participants.
The verdict
NCT03243084, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Chronic pain is a severe disabling problem within society, affecting 25-30% of the United States population.. Transcranial alternating current stimulation (tACS) has the potential to provide a treatment option that is safe, scientifically-supported, low-cost, and easy-to-administer method to effectively reduce symptoms in patients suffering from chronic pain. The purpose of this study is to test the feasibility of using tACS to treat patients with chronic pain, and to collect pilot efficacy as well as EEG and EKG biomarker data for optimizing the design of subsequent large-scale studies. The treatment rationale is to renormalize the presumed pathological structure of alpha oscillations in the prefrontal cortex (PFC) of patients with chronic pain.
Interventions
- DEVICE XCSITE100 Stimulator tACS
- DEVICE XCSITE100 Stimulator Sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2018-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03243084
The ClinicalTrials.gov registry entry for NCT03243084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which XCSITE100 Stimulator tACS is the first listed.
NCT03243084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03243084 about?
NCT03243084 is a clinical study titled "Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy". Chronic pain is a severe disabling problem within society, affecting 25-30% of the United States population.. Transcranial alternating current stimulation (tACS) has the potential to provide a treatment option that is safe, scientifically-supported, low-cost, and easy-to-administer method to effecti...
What is the current status of trial NCT03243084?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-09-07. Estimated completion is 2018-01-10.
What interventions are being tested in trial NCT03243084?
The interventions under investigation include: XCSITE100 Stimulator tACS (DEVICE), XCSITE100 Stimulator Sham (DEVICE).
Who is sponsoring clinical trial NCT03243084?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.